// App-Quantinova.ai

E057 : A systematic review of new rheumatic immune-mediated inflammatory diseases (R-IMID) following SARS-CoV-2 vaccinations

Researchers

Presenter

  • Arvind Nune

Principal Investigators

  • Kaustubh Bora

  • Karthikeyan P Iyengar

  • Bhupen Barman

  • Victor Durkowski

  • Srinivasan Venkatachalam

  • Syed Mujtaba Haider Bilgrami

  • Lesley Ottewell

  • Ciro Manzo

Medical Centers

  • Department of General Medicine, All India Institute of Medical Sciences (AIIMS), Guwahati, India

  • Department of Haematology, The Royal Wolverhampton Hospitals NHS Trust, Wolverhampton, United Kingdom

  • Rheumatologic outpatient clinic, Azienda Sanitaria Locale Napoli 3, Sant’Agnello, Italy

  • Department of Rheumatology, Southport and Ormskirk Hospital NHS Trust, Southport, United Kingdom

  • Haematology Division, ICMR-Regional Medical Research Centre, North East Region, Dibrugarh, India

  • Department of Rheumatology, Royal Lancaster Infirmary, Lancaster, United Kingdom

Locations

  • India

  • United Kingdom

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Cardiovascular (CVS)

  • Autoimmune (AI)

  • Musculoskeletal

Disease

  • Lupus

  • Inflammatory Arthritis

  • Giant cell arteritis

  • Sjogren's syndrome

  • Scleroderma

  • Sarcoidosis

  • Myositis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Observational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final